Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
Abstract Prostate cancer is a major cause of death in males. Cyproterone acetate (CPA), the steroidal anti-androgen for part of androgen deprivation therapy, may block the androgen-receptor interaction and then reduce serum testosterone through its weak anti-gonadotropic action. In addition to CPA i...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/78b4189db5554d3684b3a82e42a3a9a9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|